查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600252

合成生物學市場：按工具、技術和最終用途分類 - 全球預測 2025-2030

Synthetic Biology Market by Tools (DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools), Technology (Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年合成生物學市值為138.8億美元，預計2024年將達到166.1億美元，複合年成長率為21.33%，到2030年將達到537.6億美元。

合成生物學結合了生物學、工程學、電腦科學和化學的元素，設計和建構新的生物組件、設備和系統，或改進現有的生物組件、設備和系統以達到有用的目的。對合成生物學的需求正在徹底改變各個領域，包括透過培育抗病作物來進行農業、透過用於藥物生產和個人化醫療的人工生物體進行醫療保健，以及透過開發分解污染物的生物體來進行環境管理。其應用範圍從生質燃料為能源）到工業領域（生產化學品、材料和酵素）。最終用途範圍延伸至學術界、研究組織和許多尋求創新解決方案應對世界挑戰的商業產業。

主要市場統計
基準年[2023] 138.8億美元
預測年份 [2024] 166.1億美元
預測年份 [2030] 537.6億美元
複合年成長率（%） 21.33%

合成生物學市場的主要成長動力包括基因工程技術的進步、生物技術研究投資的增加以及對永續和環境友善解決方案不斷成長的需求。人們對精準醫療和個人化治療的興趣日益濃厚，進一步推動了市場的進步。目前的商機主要集中在學術機構和生物技術公司之間的合作、擴展 CRISPR 技術以及整合人工智慧以改善生物設計流程。為了利用這些優勢，相關人員應優先考慮對研發的投資，建立策略夥伴關係，並與政策制定者合作以推動監管環境。然而，倫理問題、潛在的生物安全風險以及高昂的研發成本等挑戰構成了主要障礙。生物系統的複雜性可能導致不可預測的結果，這也阻礙了市場的成長。

正在考慮尖端創新，包括基因組合成、即時監測生物感測器的開發以及合成生物學在太空探勘中的作用。投資可擴展的合成生物製造技術可以顯著提高經濟效益。合成生物學市場的特點是動態成長、不斷創新和緊密的跨學科合作。為了取得成功，公司應該保持適應能力，與監管機構進行持續對話，並專注於滿足特定社會需求的突破，同時確保道德標準得到遵守。

市場動態：揭示快速發展的合成生物市場的關鍵市場洞察

供需的動態交互作用正在改變合成生物學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 增加新藥和疫苗開發的使用
    • 擴展基於合成生物學的照護現場診斷設備
    • 各種工業應用對合成生物學的需求不斷成長
  • 市場限制因素
    • 與使用合成生物學技術相關的風險
  • 市場機會
    • 基因編輯與次世代定序儀的技術進步
    • 增加研發經費和投資以擴大合成生物學應用
  • 市場挑戰
    • 使用合成生物學對生物部件進行模組化和標準化的限制

波特的五力：駕馭合成生物市場的策略工具

波特的五力框架是了解合成生物學市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解合成生物市場的外部影響

外部宏觀環境因素在塑造合成生物市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解合成生物學市場的競爭格局

合成生物學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣合成生物學市場供應商的績效評估

FPNV定位矩陣是評估合成生物市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了合成生物學市場的成功之路

對於想要加強在全球市場的影響力的公司來說，合成生物學市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加在新藥和疫苗開發的使用
      • 擴展基於合成生物學的照護現場診斷設備
      • 各種工業應用對合成生物學的需求不斷增加
    • 抑制因素
      • 與使用合成生物學技術相關的風險
    • 機會
      • 基因編輯與次世代定序的技術進步
      • 增加研發經費和投資以擴大合成生物學應用
    • 任務
      • 合成生物學在生物成分模組化和標準化的限制
  • 市場區隔分析
    • 工具：探索推動合成生物學創新的基本工具
    • 最終用途：合成生物學在改變最終用途產業的崛起
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 合成生物市場（按工具）

  • 脫氧核糖核酸工具
  • 常用工具
  • 數學建模和電腦輔助設計工具
  • 蛋白質工具
  • RNA工具

第7章合成生物市場：依技術分類

  • 生物資訊學
  • 細胞序列分析
  • 細胞合成與組裝
  • 複製
  • 微流體
  • 奈米科技
  • 體學技術
  • 定點突變

第8章合成生物市場：依最終用途

  • 農業
  • 化妝品/個人護理
  • 能源和自然資源
  • 環境
    • 生物修復
    • 生物感
  • 飲食
  • 醫療保健/製藥
    • 人工組織和組織再生
    • 藥物發現與治療
  • 紙張/纖維

第9章美洲合成生物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區合成生物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲合成生物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Asimov 和 iGEM 合作培養合成生物學領域的未來領導者
    • NREL 與領先機構合作，透過合成生物學加速生質燃料創新。
    • Moderna 透過收購日本基因組公司 Orichiro 擴大 mRNA 能力
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Arzeda
  • Batavia Biosciences BV
  • Beam Therapeutics
  • Beckman Coulter, Inc.
  • BGI Genomics Co., Ltd.
  • Codexis, Inc.
  • Conagen, Inc.
  • Creative Enzymes
  • DNA TwoPointO Inc.
  • Editas Medicine, Inc.
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Merck KGaA
  • New England Biolabs GmbH
  • Novozymes A/S
  • Precigen, Inc.
  • QIAGEN NV
  • Sangamo Therapeutics
  • Scarab Genomics, LLC
  • Synlogic
  • Synthego Corporation
  • TeselaGen Service
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-B9334AD6BE33

The Synthetic Biology Market was valued at USD 13.88 billion in 2023, expected to reach USD 16.61 billion in 2024, and is projected to grow at a CAGR of 21.33%, to USD 53.76 billion by 2030.

Synthetic biology is an interdisciplinary field that combines elements of biology, engineering, computer science, and chemistry to design and construct new biological parts, devices, and systems or to modify existing ones for useful purposes. The necessity of synthetic biology lies in its potential to revolutionize various sectors, such as agriculture, by creating disease-resistant crops; healthcare, through engineered organisms for drug production and personalized medicine; and environmental management, by developing organisms that can break down pollutants. Its application extends to biofuel production, where engineered microbes efficiently convert biomass into energy, and the industrial sector for producing chemicals, materials, and enzymes. The end-use scope extends to academia, research institutions, and a host of commercial industries seeking innovative solutions to global challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 13.88 billion
Estimated Year [2024] USD 16.61 billion
Forecast Year [2030] USD 53.76 billion
CAGR (%) 21.33%

Key growth drivers for the synthetic biology market include advancements in genetic engineering technologies, increased investment in biotech research, and a rising demand for sustainable and eco-friendly solutions. The burgeoning interest in precision medicine and tailored therapies further propels market advancements. Present opportunities focus on collaborations between academic institutions and biotech firms, expansion of CRISPR technology, and the integration of artificial intelligence for improved bio-design processes. To capitalize on these, stakeholders should prioritize investments in R&D, forge strategic partnerships, and engage with policy-makers to foster conducive regulatory landscapes. However, challenges such as ethical concerns, potential biosecurity risks, and high R&D costs pose significant barriers. Market growth is also hampered by the complexities of biological systems which can result in unpredictable outcomes.

Cutting-edge innovations are being contemplated in genome synthesis, the development of biosensors for real-time monitoring, and synthetic biology's role in space exploration. Investing in scalable synthetic bio-manufacturing technologies could significantly boost economic viability. The synthetic biology market is characterized by dynamic growth, continuous innovation, and intense collaboration across disciplines. To thrive, businesses should remain adaptable, engage in ongoing dialogue with regulatory bodies, and focus on breakthroughs that address specific societal needs while ensuring ethical standards are upheld.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Synthetic Biology Market

The Synthetic Biology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use for novel drug and vaccines development
    • Expansion of synthetic biology based point-of-care diagnostics devices
    • Accelerating demand for synthetic biology in various industrial applications
  • Market Restraints
    • Risks associated with the use of synthetic biology technology
  • Market Opportunities
    • Technological advancements in gene editing and next generation sequencing
    • Rising R&D funding and investments for expansion of synthetic biology applications
  • Market Challenges
    • Constraints of synthetic biology in modularization and standardization of biological parts

Porter's Five Forces: A Strategic Tool for Navigating the Synthetic Biology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Synthetic Biology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Synthetic Biology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Synthetic Biology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Synthetic Biology Market

A detailed market share analysis in the Synthetic Biology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Synthetic Biology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Synthetic Biology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Synthetic Biology Market

A strategic analysis of the Synthetic Biology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tools, market is studied across DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools, Protein Tools, and RNA Tools.
  • Based on Technology, market is studied across Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly, Cloning, Microfluidics, Nanotechnology, Omics Technologies, and Site-directed Mutagenesis.
  • Based on End-Use, market is studied across Agriculture, Cosmetics & Personal Care, Energy & Natural Resources, Environment, Food & Beverage, Healthcare & Pharmaceuticals, and Paper & Textile. The Environment is further studied across Bioremediation and Biosensing. The Healthcare & Pharmaceuticals is further studied across Artificial Tissue & Tissue Regeneration and Drug Discovery & Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use for novel drug and vaccines development
      • 5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
      • 5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with the use of synthetic biology technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in gene editing and next generation sequencing
      • 5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
    • 5.1.4. Challenges
      • 5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Tools: Exploring essential tools for powering innovations in synthetic biology
    • 5.2.2. End-Use: Rise of synthetic biology in transforming end-use industries
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Synthetic Biology Market, by Tools

  • 6.1. Introduction
  • 6.2. DNA Tools
  • 6.3. General Tools
  • 6.4. Mathematical Modelling & Computer-aided Design Tools
  • 6.5. Protein Tools
  • 6.6. RNA Tools

7. Synthetic Biology Market, by Technology

  • 7.1. Introduction
  • 7.2. Bioinformatics
  • 7.3. Cell Sequencing
  • 7.4. Cell Synthesis & Assembly
  • 7.5. Cloning
  • 7.6. Microfluidics
  • 7.7. Nanotechnology
  • 7.8. Omics Technologies
  • 7.9. Site-directed Mutagenesis

8. Synthetic Biology Market, by End-Use

  • 8.1. Introduction
  • 8.2. Agriculture
  • 8.3. Cosmetics & Personal Care
  • 8.4. Energy & Natural Resources
  • 8.5. Environment
    • 8.5.1. Bioremediation
    • 8.5.2. Biosensing
  • 8.6. Food & Beverage
  • 8.7. Healthcare & Pharmaceuticals
    • 8.7.1. Artificial Tissue & Tissue Regeneration
    • 8.7.2. Drug Discovery & Therapeutics
  • 8.8. Paper & Textile

9. Americas Synthetic Biology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Synthetic Biology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Asimov and iGEM Collaborate to Nurture Future Leaders in Synthetic Biology
    • 12.3.2. NREL Partners with Leading Institutions to Accelerate Biofuel Innovations through Synthetic Biology
    • 12.3.3. Moderna Expands mRNA Capabilities with Acquisition of Japanese Genomics Firm Oriciro
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Amyris, Inc.
  • 3. Arzeda
  • 4. Batavia Biosciences B.V.
  • 5. Beam Therapeutics
  • 6. Beckman Coulter, Inc.
  • 7. BGI Genomics Co., Ltd.
  • 8. Codexis, Inc.
  • 9. Conagen, Inc.
  • 10. Creative Enzymes
  • 11. DNA TwoPointO Inc.
  • 12. Editas Medicine, Inc.
  • 13. Eurofins Scientific
  • 14. GenScript Biotech Corporation
  • 15. Ginkgo Bioworks, Inc.
  • 16. Illumina, Inc.
  • 17. Integrated DNA Technologies, Inc.
  • 18. Merck KGaA
  • 19. New England Biolabs GmbH
  • 20. Novozymes A/S
  • 21. Precigen, Inc.
  • 22. QIAGEN N.V.
  • 23. Sangamo Therapeutics
  • 24. Scarab Genomics, LLC
  • 25. Synlogic
  • 26. Synthego Corporation
  • 27. TeselaGen Service
  • 28. Thermo Fisher Scientific Inc.
  • 29. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. SYNTHETIC BIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. SYNTHETIC BIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SYNTHETIC BIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY DNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GENERAL TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MATHEMATICAL MODELLING & COMPUTER-AIDED DESIGN TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY RNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SYNTHESIS & ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY OMICS TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENERGY & NATURAL RESOURCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER & TEXTILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 245. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023